Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.

Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, et al.